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Abstract
The carboxyl-terminal regions of the fibrinogen Aα chains (αC regions) form compact αC-domains
tethered to the bulk of the molecule with flexible αC-connectors. It was hypothesized that in
fibrinogen two αC-domains interact intramolecularly with each other and with the central E region
preferentially through its N-termini of Bβ chains, and that removal of fibrinopeptides A and B upon
fibrin assembly results in dissociation of the αC regions and their switch to intermolecular
interactions. To test this hypothesis, we studied the interactions of the recombinant αC region
(Aα221-610 fragment) and its sub-fragments, αC-connector (Aα221-391) and αC-domain
(Aα392-610), between each other and with the recombinant (Bβ1-66)2 and (β15-66)2 fragments and
NDSK corresponding to the fibrin(ogen) central E region, using laser tweezers-based force
spectroscopy. TheαC-domain, but not the αC-connector, bound to NDSK, which contains
fibrinopeptides A and B, and less frequently to desA-NDSK and (Bβ1-66)2 containing only
fibrinopeptides B; it was poorly reactive with desAB-NDSK and (β15-66)2 both lacking
fibrinopeptides B. The interactions of the αC-domains with each other and with the αC-connector
were also observed, although they were weaker and heterogeneous in strength. These results provide
the first direct evidence for the interaction between the αC-domains and the central E region through
fibrinopeptides B, in agreement with the above hypothesis, and indicate that fibrinopeptides A are
also involved. They also confirm the hypothesized homomeric interactions between the αC-domains
and display their interaction with the αC-connectors, which may contribute to covalent cross-linking
of α polymers in fibrin.
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(1,2). This polyfunctionality is due to the complex structure of fibrinogen molecules that have
multiple binding sites, either constitutively open or exposed after precise enzymatic cleavage
and/or conformational rearrangement. The ability to polymerize upon the action of thrombin
is the unique property of fibrinogen that mainly determines its physiological significance.
Structurally, fibrinogen is a 45 nm-long elongated dimer composed of three pairs of non-
identical polypeptide chains, designated Aα, Bβ, and γ (Fig. 1). The N-termini of the six chains,
cross-linked by a cluster of disulfide bonds, form a central part, hence named “N-terminal
disulfide knot” (3). The C-termini of Bβ and γ chains form globular modules on each end of
the molecule separated from the central part by triple-helical coiled-coils (4,5). The C-terminal
portions of the Aα chains extend from the coiled-coils and form αC regions, each comprising
about two thirds of the Aα chain (residues 221–610 in human fibrinogen). The αC region was
shown to consist of a relatively compact C-terminal portion named αC-domain (residues 392–
610) attached to the bulk of the molecule via a flexible tether named αC-connector (residues
221–391) (6–8).
Functionally, αC regions of fibrinogen are implicated with a number of important molecular
interactions including those in fibrin assembly, which are yet not well understood. Fibrin
assembly starts when thrombin converts fibrinogen into fibrin monomer by cleaving a short
N-terminal portion of the Aα chains called fibrinopeptide A (FpA). Then, the newly formed
desA-fibrin monomers spontaneously self-assemble into two-stranded oligomeric protofibrils.
Once the protofibrils reach a critical length, they aggregate laterally to form fibers, which are
organized into the branched network, a fibrin clot. After fibrin has partially formed, thrombin
cleaves fibrinopeptides B (FpB) from the N-terminal portions of the Bβ chains (9,10); this
reaction gives rise to additional intermolecular interactions that reinforce the clot (11,12).
Finally, the mature clot is stabilized by covalent cross-linking of specific amino acids by a
transglutaminase, factor XIIIa (1,2,13,14). The notion that αC regions are involved in fibrin
formation is based on three clusters of data: (i) clot formation is slowed and the clot structure
is perturbed when αC regions are removed from fibrinogen either proteolytically (15–19) or
as a result of a natural/artificial genetic defect (20–32); (ii) isolated αC fragments (19,33,34)
or αC-specific antibodies (35,36) interfere with clot formation; (iii) αC regions polymerize and
can be cross-linked by factor XIIIa, thus contributing to the clot stability (33,37–40).
It has been hypothesized that in fibrinogen the αC-domains interact intramolecularly with each
other and with the central E region via FpB, while during fibrin assembly, they dissociate
following the FpB cleavage and switch from intra- to intermolecular interaction (6,17,19,33,
41). Although this “intra- to intermolecular switch” hypothesis coherently accounts for the
location of the αC-domains in fibrinogen and fibrin and suggests a possible mechanism for the
exposure of their multiple binding sites upon conversion of fibrinogen into fibrin, it is not
universally accepted (42). The major reason for the lack of consensus is that this hypothesis is
based mainly on low resolution data obtained by electron microscopy. In order to test this
hypothesis, we used laser tweezers-based force spectroscopy to examine binding specificity
and measure the binding strength of fibrin(ogen) fragments, representing the full-length αC
region or its constituents, αC-domain and αC-connector, as well as the fragments, bearing N-
terminal portions of Bβ chains (BβN-domains) (Fig. 1). The laser tweezers technique that
enables quantification of individual protein-protein interactions is based on the ability of the
optical system to measure the rupture forces of two surface-bound protein molecules (43–
45). Recently, we used this technique to examine the role of various molecular interactions,
other than those mediated by αC-domain, in fibrin polymerization (41,46,47). Here we provide
direct evidence for specific binding of the isolated αC-domain to the FpB-containing fibrinogen
BβN-domains, but not to the fibrin βN-domains lacking FpB. In addition, we show that the
αC-domains interact with each other, but their association is weaker than the αC-BβN binding.
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The recombinant αC-fragment corresponding to the human fibrinogen αC-region (residues
Aα221-610) and its constituents, αC-connector (residues Aα221-391) and αC-domain
(residues Aα392-610), were produced in E. coli, purified and refolded as described earlier (7,
48). The purity of all fragments was confirmed by SDS-PAGE; the fragments were
concentrated to 1.0–2.0 mg/ml and kept at 4°C.
Recombinant fibrin(ogen) (B)βN-containing fragments and the monoclonal antibody
The recombinant (Bβ1-66)2 fragment mimicking the dimeric arrangement of the Bβ chains in
fibrinogen, which form two BβN-domains (Fig. 1G), was produced in E. coli and purified as
described elsewhere (49). To produce the activated (β15-66)2 fragment, corresponding to fibrin
βN-domains lacking FpB (Fig. 1H), (Bβ1-66)2 was treated with thrombin and then purified as
described earlier (49). The purity of non-activated and activated (B)βN-containing fragments
was confirmed by SDS-PAGE. The anti-Bβ1-21 18C6 monoclonal antibody (50,51) was
purchased from Accurate Chemicals (Westbury, NY).
NDSK fibrin(ogen) fragments
NDSK fragment, obtained by digestion of fibrin(ogen) with CNBr, is composed of two of each
chain Aα1-51, Bβ1-118, and γ1-78 linked together by 11 disulfide bonds (52,53). Using the
procedure described elsewhere (46,52), we prepared three variants of NDSK fragments: NDSK
retaining both FpA and FpB (Fig. 1D) by CNBr cleavage of human plasma fibrinogen; desA-
NDSK lacking FpA (Fig. 1E) by CNBr cleavage of fibrin clotted with batroxobin; and desAB-
NDSK lacking both FpA and FpB (Fig. 1F) by CNBr cleavage of fibrin clotted with thrombin.
Purified NDSK fragments were characterized by SDS-PAGE, dialyzed against 20 mM HEPES
buffer, pH 7.4, containing 150 mM NaCl, and stored at −80 °C.
Coating surfaces with proteins
Surfaces coated with the interacting proteins were prepared basically as described previously
(41,44,46). One of the interacting proteins was bound covalently to 5 µm spherical silica
pedestals anchored to the bottom of a chamber. Pedestals coated with a thin layer of
polyacrylamide were activated with 10% glutaraldehyde (1 hr, 37°C), washed thoroughly with
0.055M borate buffer pH 8.5, after which 1 mg/ml of a protein in 20 mM HEPES, pH 7.4 with
150 mM NaCl was inserted into the chamber and allowed to immobilize for 2 hrs at 4°C. After
washing the chamber with 20 volumes of the same buffer to remove the unbound protein, 2
mg/ml bovine serum albumin (BSA) in 0.055 M borate buffer, pH 8.5, with 150 mM NaCl
was added as a blocker (1 hr, 4°C). In control experiments, the BSA-containing buffer was
added right after glutaraldehyde activation followed by washing of the chamber. To convert
BβN-domains to βN-domains on the surface, the immobilized BβN-domain-containing
fragments were treated with human thrombin (1 U/ml, 37°C, 1 hr), followed by washing of the
chambers with 20 volumes of cold (4°C) 100 mM HEPES pH 7.4 containing 150 mM NaCl,
3 mM CaCl2, 2 mg/ml BSA, and 0.1% (v/v) Triton X-100 about 30 min before the
measurements. All the procedures were performed at 0–4°C and the chambers containing
protein-coated surfaces were stored at 4°C and used within 3 hrs.
The other interacting protein was bound covalently to carboxylate-modified 1.87 µm latex
beads using N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (Sigma, St.
Louis, MO) as a cross-linking agent (46). 2 mg/ml BSA in 0.055 M borate buffer, pH 8.5, was
used as a blocker. The protein-coated beads were freshly prepared, stored on ice and used
within 3 hrs. The surface density of all the proteins was at the point of surface saturation, since
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further increase of the time of immobilization did not augment the maximal binding probability;
nonetheless, the fraction of reactive molecules that have a conformation and orientation
compatible with binding was indeterminate.
The model system to study protein-protein interactions
We used a laser tweezers-based model system to study interactions between two surface-bound
proteins (44–46). Laser tweezers are an optical system that use laser light to trap and manipulate
dielectric particles such as small latex beads (43,54,55). External forces applied to the trapped
particle can be accurately measured because the angular deflection of the laser beam is directly
proportional to the lateral force applied to the particle (56–58).This system permits the
measurement of discrete rupture forces produced by surface-bound molecular pairs during
repeated intermittent contact (44,45).
To study particular protein pairs, fibrin(ogen) fragments of interest were bound to pedestals
and beads. In most cases, the αC region fragment and NDSK fragments were covalently bound
to stationary pedestals anchored to the inner surface of a flow chamber, while the smaller
proteins [αC-domain, αC-connector, (Bβ1-66)2 and (β15-66)2] were bound to the moving latex
beads. In a number of experiments, the interacting proteins were immobilized on the opposite
surfaces, which did not cause a difference in results. The suspension of protein-coated beads
(107/ml) in 100 mM HEPES buffer, pH 7.4, containing 150 mM NaCl, 3 mM CaCl2, 2 mg/ml
BSA, and 0.1% (v/v) Triton X-100 was then flowed into the chamber. One of the latex beads
was trapped by a focused laser beam and moved in an oscillatory manner so that the bead was
intermittently in contact with a stationary pedestal. The tension produced when a protein on
the latex bead interacted with a complementary molecule(s) on the anchored pedestal was
sensed and displayed as a force signal that was proportional to the strength of protein-protein
binding(46). Rupture forces from many interactions were collected and displayed as
normalized force spectra histograms for each experimental condition. The binding experiments
were performed at room temperature in 100 mM HEPES buffer, pH 7.4, containing 150 mM
NaCl, 3 mM CaCl2 with 2 mg/ml BSA and 0.1% (v/v) Triton X-100 added to reduce non-
specific interactions.
Measurement of binding strength, data processing, and data analysis
The position of the optical trap and hence a protein-coated latex bead was oscillated in a
triangular waveform at 1 Hz with a pulling velocity of 1.8 µm/s, which corresponded to a
loading rate of 800 pN/s. Contact duration between interacting surfaces varied from 10 to 100
ms. Rupture forces were collected at 2000 scans per second (0.5 ms time resolution). The results
of many experiments under similar conditions were averaged so that each rupture force
histogram represented from 103 to 104 repeated contacts of more than 10 different bead-
pedestal pairs. Individual forces measured during each contact-detachment cycle were
collected into 10 pN- or 5 pN-wide bins. The number of events in each bin was plotted against
the average force for that bin after normalizing for the total number of interaction cycles. The
percentage of events in a particular force range (bin) represents the probability of rupture events
at that tension. Optical artifacts observed with or without trapped latex beads produce signals
that appeared as forces below 10 pN. Accordingly, rupture forces in this range were not
considered when the data were analyzed. The rupture force histograms were fit empirically
with multimodal Gaussian curves using Origin 7.5® (OriginLab Corp., Northampton, MA) to
determine the position of a peak that corresponds to the most probable rupture force.
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Interactions of the αC region and its constituents with the (B) βN-domains
To check directly whether the N-terminal portions of the fibrinogen Bβ chains bind to the C-
terminal portions of the Aα chains, the recombinant (Bβ1-66)2 fragment containing two
disulphide-linked BβN-domains* (Fig. 1G) was exposed to the αC region fragment* and its
sub-fragments, comprising the αC-domain and αC-connector (Fig. 1A–C). [*For the sake of
simplicity, the word “fragment” is often omitted hereinafter and the dimeric (B)βN-domain-
containing fragments, (Bβ1-66)2 and (β15-66)2, are called (B)βN-domains.] For the
interactions of the αC region and αC-domain with the BβN-domains, similar multimode rupture
force spectra in the range of 10 to 170 pN were detected with three peaks at 30–35 pN, 70–80
pN, and 115–125 pN that were fitted with the Gaussians (Fig. 2A and 2B). The peaks had
decreasing probability of interaction with larger forces, and the cumulative probability of all
meaningful rupture forces >10 pN was as much as 82% for the αC region and 83% for the
αC-domain (Table 1). By contrast, the αC-connector was significantly less reactive with the
BβN-domains, with no characteristic peaks and the cumulative probability of forces >10 pN
equal to only 49% (p<0.01) (Fig. 2C, Table 1).
When we replaced the fibrinogen BβN-domains with the fibrin βN-domains (Fig. 1H), the
interactions of the αC region and αC-domain largely vanished and the cumulative binding
probability dropped about 2-fold (p<0.01) (Fig. 2D and 2E; Table 1), while the interactions of
the αC-connector remained unchanged (Fig. 2F). The bar graph in Fig. 2I clearly shows that
removal of FpB from the BβN-domains significantly reduced the binding probability of the
αC region and αC-domain, suggesting that the interactions were mediated by FpB. At the same
time, reactivity of the αC-connector did not seem to depend on the presence of uncleaved FpB,
indicating that the binding in the latter case was non-specific, i.e., not mediated specifically by
the N-terminal portions of the Bβ chains.
To verify the effect of FpB removal on the interactions of the αC region and αC-domain, we
treated the surface-bound BβN-domains with thrombin (1 U/ml, 37°C, 1 hr), which resulted
in FpB cleavage and formation of the fibrin βN-domain right on the surface. The rupture force
spectrum of the interactions of the thrombin-treated BβN-domains and the αC region (Fig. 2G)
appeared as a broad range of forces without well-defined peaks observed in Fig. 2A and resulted
in significant reduction of binding probability (from 82% to 52%, p<0.01). The mAb against
the N-terminal 1–21 portion of the Bβ chain caused an even more profound inhibitory effect
on the αC-BβN interactions with a binding probability of 29% (Fig. 2H, Table 1), further
confirming that the interactions with the αC-domain were mediated by the N-terminal portions
of the Bβ chains. When the surface density of the BβN-domain or the αC-domain was reduced
10-fold, the cumulative binding probability dropped to 35% and 26%, respectively (Table 1),
thus providing additional evidence for the specificity of interactions between the αC- and
BβN-domains.
Interactions of the αC region and αC-domain with NDSK
To check whether or not the binding mediated by the N-terminal portion of the Bβ chain was
limited to the specific properties of the (Bβ1-66)2 fragment, we repeated the binding
experiment with different forms of N-terminal disulphide knot (NDSK), comprising the central
part of fibrin(ogen) (Fig. 1D–F). Binding of the αC region fragment and its active sub-fragment,
αC-domain, was examined for three types of the NDSK fragments that differed by their
fibrinopeptide composition. Both FpA and FpB were intact in the NDSK (Fig. 1D), while only
FpA was missing in desA-NDSK (Fig. 1E), and both FpA and FpB were missing in desAB-
NDSK (Fig. 1F). For the interactions of the NDSK fragment with the αC region, a relatively
sharp and prominent peak was observed with the most probable rupture forces at 44±13 pN
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and higher forces of decreasing probability up to 150 pN. The overall reactivity of the proteins
was high, and the cumulative binding probability reached 88% (Fig. 3A, Table 1). The
interactions of the αC region with desA-NDSK (Fig. 3B) were much less pronounced compared
to the NDSK (Fig. 3A) with the cumulative binding probability of only 59% (p<0.01),
indicating that the N-terminal portions of the Aα chains are also involved in the binding with
the αC region. Despite the reduction of the overall binding probability, a minor peak remained
at 41±22 pN (Fig. 3B, dashed line), similar to the one resulting from the interactions of the
αC region with NDSK (Fig. 3A, dashed line). The removal of FpB in addition to FpA caused
almost complete abrogation of the interactions of desAB-NDSK with the αC region (Fig. 3C).
The range of rupture forces significantly diminished to 10–90 pN and the cumulative
probability for these interactions dropped to 15%, the value similar to the non-specific
background interactions between the αC region and BSA (Table 1).
In accordance with the behavior of the αC region, the αC-domain also interacted with the NDSK
readily, producing a wide range of forces from 10 pN to 170 pN, which could be very roughly
segregated into two peaks centering at 52±17 and 128±26 pN (Fig. 3D, dashed line). As it was
shown for the αC region, the αC-domain was reactive with desA-NDSK (Fig. 3E), however,
the cumulative probability was somewhat lower than with the NDSK (71% vs. 89%, p<0.05).
The moderate peak centering at 34±17 pN could be revealed after fitting analysis suggesting
that the cleavage of FpA only partially reduced the interactions of NDSK with the αC-domain.
Accordingly, the mAb against Bβ1-21 did not completely abrogate the interactions between
the αC domain and NDSK with the cumulative probability remaining at the level of 56% (Table
1), far above those of the non-specific background, indicating that the blocked N-terminal
portions of the Bβ chains comprise only a part of the interaction site(s) for the αC domain. By
contrast, the inhibition of binding between the αC-domain and desA-NDSK with the anti-
Bβ1-21 mAb was almost complete (Fig. 3F), confirming the important contribution of the N-
terminal portions of the Bβ chains to the reactivity of NDSK with the αC-domain. The removal
of FpB from desA-NDSK caused abrogation of the interactions of desAB-NDSK with the
αC-domain (Table 1), as it did with the αC region. Comparing the histograms depicted in Fig.
3 and the data shown in Table 1, it is clear that the presence of both FpA and FpB was important
for the interaction of the NDSK fragments with the αC region and αC-domain.
Interactions of the αC region, αC-domain, and αC-connector with each other
To check directly whether the αC region and its constituents, the αC-domain and αC-connector,
can bind to each other, they were allowed to interact in different combinations. The pedestal-
bound αC region reacted with the αC region coupled to a bead (Fig. 4A); similarly, the pedestal-
bound αC-domain reacted with the αC-domain coupled to a bead (Fig. 4B). Both types of
interactions produced similar rupture force spectra ranging from 10 pN to 65 pN with three
peaks centering at about 20 pN, 40 pN, and 50 pN. The cumulative probabilities of those
interactions were very similar, 62% and 63% for the αC-domain and αC-connector,
respectively (Table 1). The probabilities were, however, significantly smaller (p<0.05) than
those observed for the interactions of the αC region and αC-domain with the BβN-domains
and NDSK, despite comparable surface densities of the reacting proteins. The αC region and
αC-domain both were poorly reactive with the αC-connector as inferred from the relatively
low binding probabilities (26% and 31%, respectively); however, they formed moderate peaks
of rupture forces at about 25–30 pN, indicating that the proteins were not fully inert (Fig. 4C
and D; Table 1). When the αC-connector was exposed to itself, the interactions formed a
decreasing spectrum of rupture forces without any peaks and with a binding probability of 27%
(Fig. 4E), characteristic of the non-specific protein-protein interactions.
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The long-standing interest in the role of the C-terminal parts of the fibrinogen Aα chains,
referred to as “αC-domains”, in fibrin polymerization (6,8,15–19,22,26,33,35,36,38–40,59–
61) has led to the current notion that the αC-domains are important participants of fibrin clot
formation, although this is still controversial (42). There is evidence that the αC-domains
accelerate fibrin polymerization and make the ultimate clot structure more stable, stiff, and
resistant to fibrinolysis (32). It has been proposed that in fibrinogen the αC-domains interact
intramolecularly with each other and with the central region and, during fibrin assembly, the
αC-domains switch from intra- to intermolecular interaction, thus promoting lateral
aggregation of protofibrils (6,17). This hypothesis is based largely on the indirect evidence
obtained by differential scanning calorimetry (59,60) and transmission electron microscopy
(19,33,61–63), demonstrating that in fibrinogen a pair of the αC-domains shows up as a
globular particle near the central region, while in fibrin monomer they extend away from the
backbone, forming two separate appendages. Many other experiments that utilized
heterogeneous fibrin(ogen) degradation products or heterozygous dysfibrinogens (6) get at the
αC-mediated interactions far less directly, making interpretation difficult and sometimes
ambiguous. Therefore, the ability of the αC domains to form specific associations still has been
a matter of debate (42). In this study, for the first time, we directly observed and quantified the
bimolecular interactions between recombinant fibrin(ogen) fragments containing the C-
terminal parts of the Aα chains and the N-terminal portions of the Bβ chains, thus reproducing
the intramolecular associations of the αC-domains with the central part of the fibrinogen
molecule and between each other. The results clearly show that there are specific interactions
between the αC-domains and the central E region, which are partially reduced after cleavage
of FpA and are fully abrogated upon FpB removal. In addition, the αC-domains form relatively
weak homomeric associations, which are still stronger and more stable than the non-specific
background protein-protein interactions.
Although the whole αC region (Aα221-610) is reactive with the fragments derived from the
fibrinogen E region, its binding capacity is largely determined by the relatively compact C-
terminal portion, the αC-domain (Aα392-610), but not by the unstructured N-terminal αC-
connector (Aα221-391). The αC region and αC-domain fragments both had remarkable and
similar rupture force profiles with (Bβ1-66)2 (Fig. 2A and B) and NDSK (Fig. 3A–B and D–
E), while the αC-connector was significantly less reactive and displayed a qualitatively
different behavior, showing rupture force profiles of lower cumulative probability (Table 1)
without well-defined force peaks (Fig. 2C and F). The overall force profile with exponentially
decreasing binding probability with larger forces, observed for the αC connector, is
characteristic of non-specific background interactions (45, 64). In addition, the reactivity of
the αC-connector, unlike the αC region and αC-domain, was independent of the presence or
absence of FpB in the BβN- or βN-domains (Fig. 2C, F and I), indicating that the binding was
not mediated specifically by the N-terminal portions of the Bβ chains and rather reflected non-
specific protein-protein interactions. Therefore, it is the αC-domain, but not the αC-connector
that serves as the reactive part of the αC region and is directly involved in the molecular
interactions with the BβN-domains.
It was hypothesized that intramolecular interactions between the αC-domains and the central
E region of fibrinogen were mediated by the N-terminal portions of the Bβ chains, including
FpB (19). This assumption was tested and proved in this paper by direct exposure of the αC
regions and αC-domains to the recombinant (Bβ1-66)2 fragment mimicking the dimeric
arrangement of the BβN-domains in fibrinogen. Both the αC regions and αC-domains readily
reacted with (Bβ1-66)2 producing a multimode rupture force spectrum (Fig. 2A and B). These
interactions vanished when this BβN-domain-containing fragment was replaced with the
(β15-66)2 fragment, containing two βN-domains (Fig. 2D, E and I; Table 1). In addition, the
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interactions of the αC regions and αC-domains with (Bβ1-66)2 could be abrogated by direct
cleavage of FpB by thrombin on the surface (Fig. 2G) or blocking the N-terminal portions of
the Bβ chains by the anti-Bβ1-21 mAb (Fig. 2H). The susceptibility of the interactions to the
presence or absence of exposed FpB indicates that the binding is specifically mediated by the
N-terminal 1–14 portions of the Bβ chains corresponding to FpB.
When (Bβ1-66)2 and (β15-66)2 were replaced with the NDSK fragments, which represent
larger and more complex parts of fibrin(ogen) central E region, the critical importance of FpB
for binding with the αC-domains has been generally confirmed. In addition, it was found that
the cleavage of FpA from NDSK, resulting in formation of desA-NDSK, partially reduced the
ability of the αC regions and αC-domains to bind the isolated central E region (Fig. 3A–B and
D–E). Further cleavage of FpB from desA-NDSK, resulting in formation of desAB-NDSK,
precluded binding to the αC regions (Fig. 3C), as did the treatment of desA-NDSK with the
anti-Bβ1-21 mAb (Fig. 3F). These findings indicate that, in addition to FpB, the N-terminal
portions of the Aα chains are also involved in the intramolecular interactions between the αC-
domains and the central E region of fibrinogen. It should be noted that the cleavage of FpA
itself does not seem to be sufficient for dissociation of the αC-domains from the central E
region, as revealed by the previous electron microscopy analysis of desA- and desAB-fibrin
(33). Thus, the FpB-mediated interactions appear to be critical for formation and maintaining
of the intramolecular complex between the αC-domains and the central E domain in fibrinogen,
while the FpA-αC interactions are likely to reinforce this complex and contribute to its stability.
Detailed analysis of the rupture force spectra enables us to quantify the strength of interactions
at the single-molecule level. There are several indirect arguments favoring the idea that the
three decreasing peaks of rupture force histograms in Fig. 2A and B are indicative of the single,
double, and triple αC-BβN binding, respectively. First, the maximum values of the weak (20–
40 pN), intermediate (50–90 pN), and strong (100–150 pN) force peaks are roughly quantized,
as would be predicted if they represent multiples of the bimolecular interactions (65). Second,
the observed decreasing peak areas generally correspond to statistically predicted relative
probabilities of the single, double, and triple molecular interactions. Third, the stronger forces
are more susceptible to the inhibitory effects of FpB cleavage and the mAb treatment (Fig. 2
and Fig. 3), which is consistent with the assumption that the stronger forces reflect multiple
interactions and, therefore, disappear first. Fourth, the high incidence of multiple
intermolecular interactions is confirmed by the relatively common occurrence of stepwise
detachment of the interacting surfaces (10–20%). Taken together, these considerations suggest
that the binding strength of the individual αC-BβN interactions represented by the weakest
peaks in the force spectra should be about 20–40 pN.
The hypothesized ability of the αC-domains to switch from intra- to intermolecular interaction
during fibrin assembly implies that they bind each other specifically. This possibility was
proved earlier by the fact that αC regions form homopolymers mimicking the arrangement of
the αC-domains in fibrin (33,39), although the bimolecular binding between the isolated αC
regions and/or its constituent parts has never been demonstrated. Our data clearly show that
the αC regions do interact with each other at the single-molecule level and that the binding is
mostly mediated by the αC-domains rather than the αC-connectors (Fig. 4,Table 1). The rupture
force histograms produced by the αC-αC interactions differ from the αC-BβN binding in two
respects; first they are significantly weaker (<60 pN vs. <160 pN, respectively) and, second,
they seem to be more heterogeneous since the areas of the first, second, and third peaks are not
very different (Fig. 4A). Although it is tempting to attribute the weakest peak in the force
spectrum to single-molecule binding, with other peaks being multiples, the remarkable
heterogeneity of the interactions does not allow doing that unambiguously. The complexity of
these peaks may reflect multiple binding sites involved in αC-αC interactions. Indeed, at least
two different types of binding sites are necessary to yield the linear α-polymers formed by the
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αC-domains (6). Therefore, we infer that the αC-domains can form relatively weak and unstable
homomeric associations. In fibrinogen, these associations are reinforced by the interactions of
the αC-domains with the central E region via FpA and FpB. In fibrin, the αC-αC interactions
are reinforced by the covalent factor XIIIa-mediated cross-linking.
It is noteworthy that the interactions revealed in this study between the fragments
corresponding to the αC-domain and αC-connector, although quite weak and infrequent (Fig.
4D), still exceed the nonspecific background (Fig. 4F). This suggests that they have a specific
component and may reflect those occurring in fibrin. To speculate about a possible
physiological role of these interactions, one should recollect that the reactive Lys and Gln
residues involved in covalent cross-linking of αC regions are located exclusively in their αC-
domains and αC-connectors, respectively (38). This implies that in order to form cross-linked
α polymers in fibrin, factor XIIIa should cross-link the αC-domains and αC-connectors of the
neighboring molecules. In this case, the non-covalent interactions between the αC-domains
and αC-connectors may bring them together and provide proper orientation of the cross-linking
sites to facilitate the covalent cross-linking and thereby reinforcement of α polymers in fibrin.
In conclusion, these results confirm the existence of the intramolecular interactions in
fibrinogen between the αC-domains and the central E region. They provide the first direct
evidence that these interactions are mediated by fibrinopeptides B and that fibrinopeptides A
are also involved. In addition, the specific interactions were demonstrated between two
identical αC-domains and between the αC-domains and the αC-connectors. Taken together,
these results support the “intra- to intermolecular switch” hypothesis and provide insight into
various αC-mediated interactions in fibrinogen and fibrin.
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Figure 1. Cartoon of fibrinogen and fibrin(ogen) fragments used in this study
A, B, and C show the αC region fragment corresponding to the C-terminal portion of the
fibrinogen Aα chain (residues Aα221-610) and its sub-fragments, the αC-domain (residues
Aα392-610) and αC-connector (residues Aα221-391), respectively. D, E, and F show NDSK
[“N-Terminal DiSulphide Knot”(3)], a fragment from the central part of fibrinogen containing
both FpA and FpB, desA-NDSK with cleaved FpA but remaining FpB, and desAB-NDSK
with both FpA and FpB cleaved, respectively. G shows the recombinant fibrinogen
(Bβ1-66)2 fragment consisting of two BβN-domains formed by the N-terminal portions of the
fibrinogen Bβ chain. H shows the recombinant fibrin fragment (β15-66)2 including two βN-
domains devoid of fibrinopeptides B. The grey and black circles on the ends represent
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fibrinopeptides A (FpA) and B (FpB), respectively. The gray circle in the center with double
designations “S-S” inside represents a cluster of disulphide bonds.
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Figure 2. The panel of rupture force histograms demonstrating interactions of the recombinant
fragment corresponding to the αC region and its sub-fragments, αC-connector and αC-domain,
with the recombinant (Bβ1-66)2 and (β15-66)2 fragments corresponding to the fibrinogen BβN-
and fibrin βN-domains, respectively
A, B, and C – interactions of the BβN-domains with the αC region, αC-domain, and αC-
connector, respectively; D, E, and F - interactions of the βN-domains with the αC region, αC-
domain, and αC-connector, respectively; G - interactions of the αC region with the BβN-
domains treated with thrombin and thus converted to the βN-domains right on the surface; H
- interactions of the αC-domain with the BβN-domains in the presence of 200 µg/ml anti-
Bβ1-21 mAb; I – paired bars representing cumulative probabilities of forces >10 pN derived
from A and D, B and E, and C and F. The dashed lines show the fitting with Gaussian curves
to determine the position of each peak that corresponds to the most probable rupture force.
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Figure 3. The panel of rupture force histograms demonstrating interactions of the recombinant
αC region and αC-domain with various NDSK fragments corresponding to the central E region of
fibrin(ogen)
A, B, and C - interactions of the αC region with NDSK, desA-NDSK, and desAB-NDSK,
respectively; D and E - interactions of the αC-domain with NDSK and desA-NDSK,
respectively; F – the same as in E, but in the presence of 200 µg/ml anti-Bβ1-21 mAb. The
dashed lines show the fitting with Gaussian curves to determine the position of each peak that
corresponds to the most probable rupture force.
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Figure 4. The panel of rupture force histograms demonstrating interactions of the αC region and
its sub-fragments, αC-domain and αC-connector
A - interactions of the pedestal-bound αC region with the αC region coupled to a bead; B - the
pedestal-bound αC-domain with the αC-domain coupled to a bead; C, D, and E – the pedestal-
bound αC region, αC-domain, and αC-connector with the αC-connector coupled to a bead,
respectively; F - the pedestal-bound αC-domain with the BSA-coated bead (negative control).
The dashed lines show the fitting with Gaussian curves to determine the position of each peak
that corresponds to the most probable rupture force.
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